Levothyroxine Sodium
- Product NDC
- 70934-411
- 11-digit product format
- 709340411
- Labeler code
- 70934
- Product ID
- 70934-411_a12b4de7-6ca5-14b0-e053-2995a90a7f7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA209713
- Marketing category
- ANDA
- Marketing start
- 2019-07-19
- Marketing end
- 0000-00-00
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 0 mg/1
- Pharmacologic classes
- l-Thyroxine [EPC],Thyroxine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-411-30 | 70934041130 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-411-30) | 30 tablet | 2020-01-10 | 0000-00-00 | No | No | Current |
| 70934-411-90 | 70934041190 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-411-90) | 90 tablet | 2019-07-19 | 0000-00-00 | No | No | Current |
| 70934-411-97 | 70934041197 | 100 TABLET in 1 BOTTLE, PLASTIC (70934-411-97) | 100 tablet | 2019-08-23 | 0000-00-00 | No | No | Current |